发明授权
EP1027047B1 EPROSARTAN ARGINYL CHARGE-NEUTRALIZATION-COMPLEX AND A PROCESS FOR ITS PRODUCTION AND FORMULATION
有权
普沙坦精氨电荷中和复杂AND METHOD FOR ITS和管理
- 专利标题： EPROSARTAN ARGINYL CHARGE-NEUTRALIZATION-COMPLEX AND A PROCESS FOR ITS PRODUCTION AND FORMULATION
- 专利标题（中）： 普沙坦精氨电荷中和复杂AND METHOD FOR ITS和管理
-
申请号： EP98939213.9申请日： 1998-08-04
-
公开(公告)号： EP1027047B1公开(公告)日： 2006-10-04
- 发明人: GUDIPATI, Manga, R. , JUSHCHYSHYN, John, M. , PALEPU, Nageswara R. , VENKATESH, Gopadi, M.
- 申请人： SMITHKLINE BEECHAM CORPORATION
- 申请人地址： One Franklin Plaza P.O. Box 7929 Philadelphia, PA 19101 US
- 专利权人： SMITHKLINE BEECHAM CORPORATION
- 当前专利权人： SMITHKLINE BEECHAM CORPORATION
- 当前专利权人地址： One Franklin Plaza P.O. Box 7929 Philadelphia, PA 19101 US
- 代理机构： Blakey, Alison Jane
- 优先权： US54990P 19970806
- 国际公布： WO1999007365 19990218
- 主分类号： A61K31/415
- IPC分类号： A61K31/415 ; C07D233/02 ; C07D233/04 ; C07D409/06
摘要：
This invention relates to (E)-α-[2-n-butyl-1-[(4-carboxyphenyl)methyl]-1H-imidazol-5-yl]methylene-2-thiophenepropionic acid arginyl charge-neutralization-complex, a process for its production, compositions containing the compound and methods of using the compound to block angiotensin II receptors and to treat hypertension, congestive heart failure and renal failure.
公开/授权文献
信息查询
